Vaccinex, Inc. (VCNX) Net margin 2017–2024
Vaccinex, Inc. (VCNX) net profit margin by fiscal year — reported net income divided by reported revenue.
-3100.5%FY2024 · since FY2017: -20802.2% → -3100.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -3100.5% | +452.3 pp |
| FY2023 | -3552.8% | +3652.6 pp |
| FY2022 | -7205.5% | -4718.8 pp |
| FY2021 | -2486.7% | +2129.5 pp |
| FY2020 | -4616.2% | +1476.2 pp |
| FY2019 | -6092.4% | -2015.3 pp |
| FY2018 | -4077.1% | +16725.2 pp |
| FY2017 | -20802.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice